SARAH ROWLING: Open Payments
NPI 1568550697 · MONROEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 13 payments from 9 companies in 2025. Trend: 2023 $115 · 2024 $354 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $204 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Lilly USA, LLC | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| ACADIA Pharmaceuticals Inc | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $17 |
Products named: BOTOX, QULIPTA, PONVORY, KESIMPTA, VYALEV, AMYVID, HORIZANT, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
